“A new problem has emerged with the federal government’s Open Payments system, which is supposed to go live Sept. 30 and disclose payments to physicians by pharmaceutical and medical device companies.
A couple weeks ago, the U.S. Centers for Medicare and Medicaid Services said it would be withholding information on one-third of the payments, citing data inconsistencies in company submissions.
Now, a source familiar with the matter tells ProPublica that CMS won’t disclose another batch of payments: research grants made by pharmaceutical companies to doctors through intermediaries, such as contract research organizations. In these cases, doctors apparently have not been given a chance to verify and dispute payments attributed to them, as required by law.
Officials at CMS have not publicly disclosed anything about this latest batch of withheld data and did not answer questions from ProPublica about how many records are involved.
The data is required to be disclosed under the Physician Payment Sunshine Act, part of the 2010 Affordable Care Act. Sen. Charles Grassley, R-Iowa, one of the main proponents of the law, expressed frustration with the reporting system’s troubles.
“CMS has had more than four years to figure everything out,” Grassley said in a statement Thursday. “It’s disappointing and irresponsible that so many basic questions are unresolved at this late stage.””